The federal government is asking travellers coming from Hubei province to voluntarily isolate themselves for 14 days.
“If you have travelled to Hubei province in the last 14 days, limit your contact with others for a total of 14 days from the date you left Hubei,” reads the government’s webpage on the virus.
“This means self-isolate and stay at home (sic).”
The request marks an escalation from the country’s top health officials, who until recently have asked returning travellers to monitor their health and seek medical attention if they have any symptoms of novel coronavirus.
Symptoms of the virus include a fever, cough and difficulty breathing.
As the research and data on the virus continues to grow and evolve, the government says it will continue to adapt its advice for travellers.
Some evidence, according to Dr. Theresa Tam, the country’s chief public health officer, suggests the coronavirus may spread to others even when symptoms are in early stages or the illness is mild.
1/3 Some evidence suggests #2019nCoV may spread to others even when symptoms are very early or the illness is mild. Maintaining #handwashing and #coughetiquette is key to prevent spread of #2019nCoV. #coronavirus #OutsmartEpidemics pic.twitter.com/zeFZMX1Hq9
— Dr. Theresa Tam (@CPHO_Canada) February 7, 2020
The federal government isn’t the only agency requesting travellers to self-isolate. Earlier this week, B.C.’s top health officials asked anyone in the province who has recently travelled to Hubei to consider staying home, and keeping their children home, for two weeks.
That request also extends to anyone who has been in close contact with someone who has recently come to Canada from Hubei, according to a joint statement Friday from B.C.’s health minister, Adrian Dix, and provincial health officer Dr. Bonnie Henry.
However, both B.C. and federal health officials state the risk to Canadians and to British Columbians remains low.
“We are watching the evolution of the outbreak in China very closely and will notify the public if the measures we need to take in B.C. change,” reads Friday’s statement from Dix and Henry.
Wuhan, Hubei’s capital city of about 11 million people and the epicentre of the outbreak, has been on an unprecedented lockdown since Jan. 23. The lockdown was eventually extended to all cities in Hubei province, affecting nearly 60 million people.
As of Feb. 8, the National Microbiology Laboratory in Winnipeg has confirmed seven positive cases of novel coronavirus in Canada, and 191 negative cases, according to the federal government. While provincial health authorities can test for novel coronavirus, these cases are only considered presumptive positive until they are confirmed by the national lab.
Four of the seven confirmed patients are in B.C. in the Vancouver Coastal Health (VCH) region, and three are in Ontario.
B.C.’s second confirmed case, a woman in her 50s who lives in the VCH region, contracted the virus from family members who were visiting from Wuhan.
On Thursday, Henry confirmed her family members, a man and a woman, had tested positive for the coronavirus. All are at home in self-isolation.
B.C. has tested a total of 210 people for the virus, as of Feb. 5.
UBC researchers say they've found 'weak spot' in all COVID-19 variants that could lead to better treatment – CBC.ca
Researchers at the University of British Columbia (UBC) have discovered what they describe as a “weak spot” in all of the major variants of the virus that causes COVID-19 — a revelation they believe could open the door for treatments to fight current and future mutations.
In a peer-reviewed study published Thursday, the research team said they found a largely consistent soft spot — like a dent in the virus’s spike protein armour — that has survived the coronavirus’s mutations to date. Scientists determined a certain antibody fragment was able to “effectively neutralize” all the variants, to some degree, because it exploited the vulnerability.
“What’s exciting is what it tells us we can do now. Once you know the [weak] spot, it’s a bit like the gold rush analogy. We know where to go,” said Sriram Subramaniam, the study’s senior author and a professor with UBC’s faculty of medicine.
“We can now use this information … to design better antibodies that can then take advantage of that [weak] site.”
Looking for the ‘master key’
Antibodies are naturally produced by the body to fight infection, but can also be created in a laboratory to administer as treatment. Several antibody treatments already exist to fight COVID-19, but their effectiveness fades against highly mutated variants like the recently dominant Omicron.
“Antibodies attach to a virus in a very specific manner, like a key going into a lock. But when the virus mutates, the key no longer fits,” Subramaniam wrote in a statement.
“We’ve been looking for master keys — antibodies that continue to neutralize the virus even after extensive mutations.”
Subramaniam said the antibody fragment identified in the paper would be that “master key.”
Matthew Miller, director of the DeGroote Institute for Infectious Disease Research at McMaster University in Hamilton, Ont., described the findings as “a really important development” in the fight against COVID-19.
“It’s been able to show that this antibody works against all of them and that’s really unique…. It certainly raises the hope that this [weak] area they’re targeting would be an area the virus would have a lot of trouble changing — even going forward, because if it were easy to change, it’s very likely [the virus] would have tried to change it already,” said Miller, who was not involved in the study.
“Now … viruses can always trick us,” he noted in an interview Thursday. “They’re smart. There’s always ways out. But what we want to do is make it as hard as possible to do that.”
High-tech imaging used to study virus
As part of the study, published in Nature Communications, the research team used a process called cryo-electron microscopy (cryo-EM) to examine the weak spot on the virus’s spike protein, called an epitope.
Cryo-EM technology involves freezing samples of the virus and taking hundreds of thousands of photos — similar to X-rays — used to recreate a 3D model of the molecule from an atomic level.
“Imagine you were the size of an atom and you could watch exactly what was going on,” Subramaniam explained.
Through the process, the team saw how antibodies interacted with virus. The antibody fragment, called VH Ab6, was able to latch on to the weak spot and neutralize the virus.
Subramaniam said drug companies could exploit the weakness to create a potentially “variant-resistant” treatment.
- Do you have a coronavirus question or news tip for CBC News? Email us at firstname.lastname@example.org
The researcher noted that developments resulting from the team’s discovery won’t be part of COVID-19 treatment in clinics for some time, but he described it as one more step in understanding the coronavirus itself and the illness it causes.
“We never know if this antibody will suddenly not be effective against the next variant or not…. But we’re just saying that it stood up really well to being able to neutralize the variants we’ve seen to date,” Subramaniam said.
The UBC team collaborated with colleagues at the University of Pittsburgh, who have been screening large antibody libraries and testing their effectiveness against COVID-19.
U.S. offers extra monkeypox vaccine doses for gay pride events – CTV News
NEW YORK –
The U.S. is setting aside an extra 50,000 doses of monkeypox vaccine for places with upcoming gay pride events, health officials said Thursday.
The number of doses sent to each place will be based on factors like the size of the event, how many health workers will be available to give shots, and how many of the attendees are considered at highest risk for catching the virus.
“More shots in arms is how we get the outbreak under control,” Bob Fenton, the White House monkey pox response coordinator, told reporters Thursday. He said the effort is an attempt to “meet people where they are.”
At least a dozen U.S. pride events are scheduled over the next two months, including large gatherings in Atlanta and New Orleans in early September. U.S. officials said they will send up to 2,000 additional doses to North Carolina, where the Charlotte Pride Festival & Parade will be held this weekend.
Southern Decadence, one of the nation’s largest LGBTQ events, is expected to attract 200,000 or more people to New Orleans over Labour Day weekend. The Bourbon Street Extravaganza, a free concert held amid the event, has been cancelled over monkey pox concerns, organizers said this week.
Frank Perez, a former grand marshal of the parade that’s the centrepiece of Southern Decadence, said a number of New Orleans gay bars have already had vaccine events. He said so far officials have done an adequate job with the vaccine campaign although “more is better.”
Dr. Rochelle Walensky, director of the Centers for Disease Control and Prevention, cautioned: “While we are offering the vaccine at these events to those at high risk, this is a two-dose vaccine series, and receiving the vaccine at the event will not provide protection at the event itself.”
Health officials also are urging other steps to prevent the spread of the virus, including temporarily limiting sexual partners.
Monkeypox is endemic in parts of Africa, where people have been infected through bites from rodents or small animals, but it wasn’t considered a disease that spreads easily among people until May, when infections emerged in Europe and the U.S.
There have been more than 39,000 cases reported in countries that have not historically seen monkey pox. The vast majority have occurred in men who have sex with men, but health officials stress that anyone can get monkey pox.
The U.S. has the most infections of any country – more than 13,500. About 98% of U.S. cases are men and about 93% were men who reported recent sexual contact with other men.
Officials say the virus has been spreading mainly through skin-on-skin contact, but they warn it might also transmit in other ways, including through touching linens used by someone with monkey pox.
People with monkey pox may experience fever, body aches, chills and fatigue. Many in the outbreak have developed extremely painful zit-like bumps. No one in the U.S. has died, but deaths have been reported in other countries.
The U.S. has a limited supply of what is considered the main weapon against the virus – a vaccine called Jynneos. The doses are currently being given to people soon after they think they were exposed. Scientists are still trying to establish how well the shots are working.
The government last week moved to stretch the supply by giving people one-fifth the usual dose, injected just under the skin, instead of a full vial injected into deeper tissue.
Many health workers may have little experience giving shots using the just-under-the-skin method, which requires different needles and syringes. Some health departments have started doing that, but some local officials have said they may need a week or more to make the change.
Officials this week announced the release of 442,000 of the smaller doses for order by state, local and territorial health departments. On Thursday, they said more is coming next week – 1.8 million doses, or 360,000 vials.
Officials also announced a new agreement with a Michigan manufacturer to help speed production of 5.5 million vaccine vials recently ordered by the U.S. government.
Under the deal, Grand River Aseptic Manufacturing will help package raw vaccine ingredients currently stored at an overseas facility owned by Bavarian Nordic, which makes the Jynneos vaccine. Officials said the extra capacity should help speed up U.S. vaccine orders, most of which weren’t expected to be delivered until next year. The Biden administration has faced weeks of criticism for not ordering more vaccine sooner.
Also on Thursday, health officials said next week they will boost the supply of TPOXX, a drug for treating monkey pox infections, by 50,000 treatment courses.
AP reporters Rebecca Santana in New Orleans and Matthew Perrone in Washington contributed to this report.
‘Weak spot’ in virus responsible for COVID-19 could mean new treatments: researchers
VANCOUVER — Researchers at the University of British Columbia have discovered what they are calling a “weak spot” in the virus that causes COVID-19.
A study published in the peer-reviewed scientific journal Nature Communications says the “key vulnerability” is found in all major variants of the SARS-CoV-2 virus.
Researchers say exploiting that weakness could pave the way for new treatments that would be effective against all strains of the illness that has killed almost 6.5-million people across the globe since it was identified more than two years ago.
The study’s senior author, Dr. Sriram Subramaniam, a professor in UBC’s faculty of medicine, says the team studied the virus at an atomic level, found the weak spot and identified an antibody fragment that can attach to it and all other variants, including the surging Omicron subvariants.
Antibodies counteract viruses by attaching like a key in a lock and are no longer effective when the virus mutates quickly, but Subramaniam says the weak spot is constant in all seven major variants of the SARS-CoV-2 virus, allowing one antibody to act as a “master key” capable of overcoming extensive mutations.
Subramaniam says the weak spot and master key identified in the study “unlock a whole new realm of treatment possibilities” that have the potential to be effective against current or future variants of the virus that causes COVID-19.
This report by The Canadian Press was first published Aug. 18, 2022.
The Canadian Press
Chile’s Economy Stagnates in Second Quarter as Demand Withers – BNN Bloomberg
Tourism shaping Osoyoos's economy in big way – Times Chronicle
UBC researchers say they've found 'weak spot' in all COVID-19 variants that could lead to better treatment – CBC.ca
Silver investment demand jumped 12% in 2019
Europe kicks off vaccination programs | All media content | DW | 27.12.2020 – Deutsche Welle
Global Media Markets, 2015-2020, 2020-2025F, 2030F – TV and Radio Broadcasting, Film and Music, Information Services, Web Content, Search Portals And Social Media, Print Media, & Cable – GlobeNewswire
Sports19 hours ago
Czechia pulls off major upset over U.S., advances to WJC semifinal vs. Canada – Sportsnet.ca
Science11 hours ago
Russian spacewalk cut short by bad battery in cosmonaut suit – The Indian Express
Tech19 hours ago
Apple iPhone 14, iPhone 14 Pro Surprise Early Release Leaked In New Report – Forbes
News19 hours ago
Census data shows linguistic diversity on the rise in Canada – Saanich News
Sports5 hours ago
Czechia upsets U.S. in World Junior quarterfinals – TSN
News9 hours ago
Wagering Online Using Real Money
Politics11 hours ago
Mintoff seeks return to politics, running to be Tiny mayor – MidlandToday
Media9 hours ago
Media Release – August 18, 2022 – Guelph Police – Guelph Police Service